Semler Scientific Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,233.00
4,515.00
8,501.00
2,554.00
1,510.00
5,014
Depreciation, Depletion & Amortization
129.00
196.00
315.00
452.00
559.00
503
Other Funds
60.00
-
-
-
-
1,100
Funds from Operations
1,627.00
3,776.00
5,110.00
1,286.00
440.00
6,617
Changes in Working Capital
435.00
46.00
975.00
518.00
181.00
1,920
Net Operating Cash Flow
1,192.00
3,822.00
4,135.00
1,804.00
621.00
4,697
Capital Expenditures
441.00
441.00
1,104.00
814.00
971.00
Sale of Fixed Assets & Businesses
-
-
-
-
3.00
Net Investing Cash Flow
441.00
2,541.00
1,104.00
814.00
968.00
Issuance/Reduction of Debt, Net
43.00
1,730.00
2,000.00
2,835.00
32.00
Net Financing Cash Flow
1,636.00
9,785.00
612.00
2,835.00
1,182.00
Net Change in Cash
3.00
3,422.00
5,851.00
217.00
835.00
Free Cash Flow
1,633.00
4,263.00
5,239.00
2,618.00
350.00
Change in Capital Stock
1,739.00
8,055.00
1,388.00
-
1,214.00
Other Uses
-
2,100.00
-
-
-

About Semler Scientific

View Profile
Address
911 Bern Court
San Jose California 95112
United States
Employees -
Website http://www.semlerscientific.com
Updated 07/08/2019
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. It is also involved in development, manufacturing, and marketing of proprietary products and services that assist customers in evaluating and treating chronic diseases. The company was founded by Herbert J.